NewsRadio WFLA (WFLA-AM)
NewsRadio WFLA (WFLA-AM)
DR. BRYAN ARDIS – COVID-19 VACCINE REPORT PT. 2 9 18 21
DR. BRYAN ARDIS – COVID-19 VACCINE REPORT PT. 2 9 18 21
DR. BRYAN ARDIS – COVID-19 VACCINE REPORT PT. 2 9 18 21
Tuesday 21st September 2021
Dr. Bryan Ardis challenges COVID-19 treatment protocols, discussing remdesivir's risks and advocating for alternatives like ivermectin on American Medicine Today.
Explicit
9 minutes
Informative
Thought-provoking
Raw
Engaging
Eye-opening
About this podcast
Author:
NewsRadio WFLA (WFLA-AM)
Overview:
Categories:
Innovative Treatments & Recovery Paths
Holistic Health Innovations
Innovative Healing Arts
Sexual Stigmas & Myths
Mindful Recovery
Links:
Visit site
Episodes:
1002 (View all)
Do you want to link to this podcast?
Get the buttons here!Dr. Bryan Ardis on COVID-19 Treatments: Uncovering the Controversy
We need ivermectin and things like hydroxychloroquine, cheap and effective. This is holocaust numbers in Months or less. Remdesivir poisoning: what is every reported dead person reported on their death certificate? It's not pneumonia, it's pulmonary edema flooding their lungs with water, shutting down their kidneys with remdesivir.
Have you ever wondered if the treatments we're being told to trust for COVID-19 are really the best options? In this episode of 'American Medicine Today', Dr. Bryan Ardis dives into the murky waters of hospital protocols and COVID-19 treatments. He doesn't hold back, discussing how hospital misconduct and poor protocols have led to more deaths than necessary. Dr.
Ardis shines a spotlight on remdesivir, a drug heavily promoted as a COVID-19 treatment, revealing that it has the highest death rate among the experimental drugs tested. He argues that Anthony Fauci's claims about remdesivir's safety and effectiveness are misleading. Instead, Dr. Ardis champions cheaper alternatives like ivermectin and hydroxychloroquine, which he believes could save lives.
This episode is a rollercoaster of revelations and challenges the status quo, making it a must-listen for anyone interested in the ongoing debates around COVID-19 treatments.